H
Hideki Maeda
Researcher at Sapporo Medical University
Publications - 21
Citations - 272
Hideki Maeda is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 5, co-authored 14 publications receiving 195 citations.
Papers
More filters
Journal ArticleDOI
RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated
Atsushi Tanabe,Kenya Tanikawa,Mai Tsunetomi,Kaori Takai,Hiroto Ikeda,Junpei Konno,Toshihiko Torigoe,Hideki Maeda,Goro Kutomi,Kenji Okita,Mitsuru Mori,Hiroeki Sahara +11 more
TL;DR: It is suggested that the RNA helicase YTH DC2 contributes to colon tumor metastasis by promoting translation of HIF-1α and that YTHDC2 is potentially a diagnostic marker and target gene for treating colon cancer patients.
Journal ArticleDOI
Biological Heterogeneity of the Peptide-binding Motif of the 70-kDa Heat Shock Protein by Surface Plasmon Resonance Analysis
Hideki Maeda,Hiroeki Sahara,Yoko Mori,Toshihiko Torigo,Kenjiro Kamiguchi,Yutaka Tamura,Yasuaki Tamura,Kouichi Hirata,Noriyuki Sato +8 more
TL;DR: This study presents a new binding motif between Hsp70 and peptides derived from the natural protein human leukocyte antigen B*2702 and may also elucidate some characteristics of the HSp70 binding characteristic, enhancing the understanding of Hsp 70-binding determinants that may influence diverse cellular and physiological processes.
Journal ArticleDOI
Current status of the prognostic molecular biomarkers in breast cancer: A systematic review.
Goro Kutomi,Toru Mizuguchi,Fukino Satomi,Hideki Maeda,Hiroaki Shima,Yasutoshi Kimura,Koichi Hirata +6 more
TL;DR: A systematic review of the literature between 2009 and 2014 was conducted by searching for the keywords 'breast cancer', 'biomarkers', 'diagnosis', 'prognosis' and 'drug response' to clarify the present state of knowledge regarding biomarkers.
Journal Article
SOX2 and ALDH1 as Predictors of Operable Breast Cancer
Hiroaki Shima,Goro Kutomi,Fukino Satomi,Hideki Maeda,Yoshihiko Hirohashi,Tadashi Hasegawa,Mitsuru Mori,Toshihiko Torigoe,Ichiro Takemasa +8 more
TL;DR: SOX2 and ALDH1 can be considered markers of poor prognosis, particularly in ER-negative patients, and SOX2/ALDH1 any-positivity might also offer a reliable predictor ofpoor prognosis.
Journal ArticleDOI
Comparison of surgical outcomes and complications between the Harmonic FOCUS and conventional surgery for open thyroidectomy
TL;DR: The present study suggests that open thyroidectomy using the Harmonic FOCUS (HF) as an ultrasonic scalpel is safe and effective and not associated with any increase in complications.